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Despite of the astounding complexity of biological 
systems, the history of biology is marked by attempts to 
discern generalizable principles. Functional genomics 
and its ultimate integration with systems biology remain 
pivotal to enabling advances in experimental technology 
that provide detailed and comprehensive information 
about networks of biological interactions. The Functional 
Genomics and Systems Biology 2011 conference focused 
on recent, largely unpublished developments in sequen­
cing­based approaches and computational methods, 
including their application to chromatin and proteome 
systems biology. Experts at the meeting also discussed 
advances in translating these findings to the clinic, with 
the ultimate goal of promoting personalized medicine. 
Here, we summarize some of the highlights presented at 
this exciting conference.
Yeast leads the way in systems biology
A relatively simple genome and the availability of power­
ful methods for their genetic manipulation make yeast 
models the central paradigm in systems biology. Brenda 
Andrews (University of Toronto, Canada) presented the 
latest applications of synthetic genetic array (SGA) tech­
nology to proteome localization, allowing quantitative 
determination of subcellular localizations for the 
majority of yeast proteins. Published work from the 
laboratories of Andrews and Charles Boone (University 
of Toronto, Canada) exploited the SGA method to 
produce a genome­scale landscape of genetic interactions 
in Saccharomyces cerevisiae. Integration of this tech­
nology with high­content microscopy screening of a 
green fluorescent protein fusion library allowed con­
struction of abundance localization networks across the 
yeast proteome, including flux networks of dynamic 
protein localization changes. Frank Holstege (University 
Medical Center Utrecht, The Netherlands) emphasized 
the importance of specificity and redundancy in under­
standing regulatory processes. Work in his laboratory 
employed gene expression changes in S. cerevisiae upon 
single or double deletion of 165 chromatin machinery 
components to build a global network of chromatin inter­
action pathways, characterized by remarkably specific 
effects on gene expression for a majority of chromatin 
regulators. A similar analysis focused on kinase/phos pha­
tase deletions revealed general principles of redundancy 
in signaling networks. Holstege argued that the majority 
of genetic interactions are non­intuitive and underlie a 
combination of partial redundancy and regulatory coup­
ling, allowing a single node in the network to couple/
uncouple two distinct responses.
Jurg Bahler (University College London, UK) and Simon 
Tavaré (University of Cambridge, UK) also presented 
interesting technological developments in yeast. Bahler’s 
talk focused on a quantitative comparison of the fission 
yeast transcriptome and proteome using nCounter/RNA­
Seq and liquid chromatography­tandem mass spectro­
metry (LC­MS/MS), and provided quantitative support 
for previously noted differences in mRNA/long non­
coding RNA average abundance, as well as a much higher 
abundance and dynamic range for proteins. Correlation 
of protein/mRNA abundance additionally suggests that 
there is considerable scope for translational (in addition 
to transcriptional) control. Tavaré presented a detailed 
model of yeast replication dynamics based on time­
course chromatin immunoprecipitation sequencing 
(ChIP­Seq) analysis of G1­synchronized yeast cells 
labeled with bromodeoxyuridine.
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Functional genomics and systems biology unite in 
metazoan systems
In contrast to the more traditional static snapshots of 
cellular state, several speakers at the conference discussed 
novel functional genomics approaches to explore and 
rationalize biological heterogeneity. We and others are 
exploiting ChIP­Seq and RNA­Seq to understand the 
evolutionary principles of regulatory divergence across 
transcription factors (TFs) and non­coding RNAs. Based 
on modeling of high­throughput RNA interference 
(RNAi) screening, Chris Bakal (The Institute of Cancer 
Research, UK) elaborated on a model of morphogenesis 
as a switch­like, versus continuous, transition between 
stable morphological states (analogous to molecular con­
for mations). Sarah Teichmann (MRC Laboratory of 
Molecular Biology, UK) presented detailed analyses of 
RNA­Seq data in mouse Th2 cells that show a bimodal 
gene expression distribution of protein­coding genes 
indicative of putatively non­functional lowly expressed 
genes and functional highly expressed genes. Mike White 
(University of Manchester, UK) discussed the related 
concept of cell­to­cell heterogeneity and its effect in 
transcriptional responses, revealed through extensive 
biochemical studies and simulations based on single­cell 
observations. These findings argue for an important 
biological role of transcriptional heterogeneity and 
precise control of oscillatory cellular dynamics, which 
likely contribute to population robustness by mitigating 
the effect of temporal fluctuations in paracrine signaling.
A major highlight of the conference was the presen­
tation of insightful works that employed functional 
genomics to build systems biology models of metazoan 
transcription, moving beyond the yeast system. Ido Amit 
(Weizmann Institute of Science, Israel) presented 
unpublished work on the development and validation of 
an Indexed high­throughput ChIP­Seq method (iChIP) 
to study dynamic occupancy of 40 transcription factors 
during stimulation of mouse dendritic cells with the toll­
like receptor agonist lipopolysaccharide, thereby model­
ing their transcriptional response to pathogens. Among 
the insights made by this work is a model of a layered 
transcriptional regulation in three levels: organizers 
(pioneering TFs), controlling chromatin accessibility, 
primers (control of basal expression levels) and trans­
ducers (dynamic DNA­binders in response to stimuli). 
Building on published efforts to model enhancer activity 
from TF occupancy during Drosophila melanogaster 
mesoderm development, Eileen Furlong (European 
Mole cu lar Biology Laboratory, Germany) presented a 
method that facilitates cell­type­specific ChIP­Seq based 
on fluorescence­activated cell sorting of covalently cross­
linked transgenic embryos. Integration of information on 
histone modifications and polymerase II occupancy with 
a large collection of developmental enhancers of known 
activity has led to predictive models and uncovered 
general principles of the relationship between TF occu­
pancy and chromatin marks at dynamically activated 
enhancers. Phil Arnold (University of Basel, Switzerland) 
discussed published work within the FANTOM Consor­
tium (http://fantom.gsc.riken.jp/) on modeling of gene 
expression dynamics during monocyte differentia tion as 
a linear function of predicted transcription factor binding 
sites (TFBSs). Arnold presented the adaptation of this 
method to modeling of genome­wide profiles of chro­
matin marks in terms of predicted TFBSs; this points to 
candidate regulators for recruitment of specific chroma­
tin modifications (for example, H3K27me3).
A number of talks in the meeting addressed regulatory 
aspects beyond transcription, suggesting additional 
scope for regulation. Lars Dolken (Cambridge University, 
UK) elaborated on the kinetics of RNA processing as 
inferred from a combination of progressive 4­thiouridine 
tagging and RNA­Seq. Results have pointed to several 
classes of splicing kinetics for coding and non­coding 
RNAs, including remarkably inefficient processing of 
small nucleolar RNAs. Piero Carninci (RIKEN Yokohama 
Institute, Japan) presented published and ongoing work 
from the FANTOM Consortium that extensively exploits 
Deep cap analysis of gene expression (DeepCAGE) 
technology for transcriptome analysis. Time­course 
analysis of a panel of a hundred primary cells revealed 
submodalities of promoter architecture associated with 
tissue­specific transcription (enrichment of TATA pro­
mo ters) versus ubiquitous expression (mostly CpG 
promo ters). Carninci’s results also explored dynamic and 
spatial expression of repeat elements, pointing to 
preferential retrotransposon (LINE and SINE repeats) 
expression in nuclear fractions and a role for SINEs in 
regulation of protein synthesis.
Moving towards personalized medicine
About a third of the talks in the conference discussed 
recent applications of functional genomics to various 
pathological settings, including complementary approaches 
to genome­wide association studies, such as employing 
gene and protein networks for identification of candidate 
disease genes (Thomas Schlitt, King’s College London, 
UK) and the use of functional interaction networks for 
drug target identification (Nicola Mulder, University of 
Cape Town, South Africa). Keith Baggerly (MD Anderson 
Cancer Center, USA) stressed the scientific and ethical 
importance of reproducibility and rigorously controlled 
bioinformatics in high­throughput biology, even more so 
for research that may eventually lead to clinical trials. Of 
particular originality and scientific implication was 
Michael Snyder’s (Stanford University, USA) presentation 
on his own personal profile followed over a 21 month 
period using an integrated ’omics approach; his profile 
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included normal and virally infected states. This 
pioneering study integrated genome sequencing with 
profiling of the epi genome, transcriptome, proteome, 
metabolome, auto anti bodiome and microbiome to 
correlate heteroallelic expression with disease state. The 
results illustrated the potential of integrated functional 
genomics to predict disease risk, with important 
implications for the ultimate development of 
personalized medicine.
Towards convergence of functional genomics and 
systems biology
As the cost of sequencing continues to drop and related 
technologies develop, increasingly comprehensive studies 
based on functional genomics are becoming feasible. A 
major challenge remains in adequately and reproducibly 
adapting analysis and biological interpretation efforts to 
the vast amounts of datasets generated. Nevertheless, 
groundbreaking work presented at this exciting 
conference exemplified the current potential of these 
approaches to produce systems biology models of bio­
logical interactions, explore sources of biological hetero­
geneity and emerging regulatory mechanisms, and inform 
disease prognosis and outcome, potentially tailoring 
predictions to each individual.
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